ELDN vs. PAHC, ELVN, COLL, ZYME, NTLA, COGT, PHVS, PSTX, RCKT, and AVBP
Should you be buying Eledon Pharmaceuticals stock or one of its competitors? The main competitors of Eledon Pharmaceuticals include Phibro Animal Health (PAHC), Enliven Therapeutics (ELVN), Collegium Pharmaceutical (COLL), Zymeworks (ZYME), Intellia Therapeutics (NTLA), Cogent Biosciences (COGT), Pharvaris (PHVS), Poseida Therapeutics (PSTX), Rocket Pharmaceuticals (RCKT), and ArriVent BioPharma (AVBP). These companies are all part of the "pharmaceutical products" industry.
Eledon Pharmaceuticals vs.
Eledon Pharmaceuticals (NASDAQ:ELDN) and Phibro Animal Health (NASDAQ:PAHC) are both small-cap medical companies, but which is the better business? We will compare the two businesses based on the strength of their risk, earnings, community ranking, media sentiment, profitability, dividends, valuation, analyst recommendations and institutional ownership.
Phibro Animal Health received 287 more outperform votes than Eledon Pharmaceuticals when rated by MarketBeat users. However, 73.68% of users gave Eledon Pharmaceuticals an outperform vote while only 60.11% of users gave Phibro Animal Health an outperform vote.
Eledon Pharmaceuticals currently has a consensus target price of $12.50, indicating a potential upside of 191.38%. Phibro Animal Health has a consensus target price of $21.00, indicating a potential downside of 6.67%. Given Eledon Pharmaceuticals' stronger consensus rating and higher probable upside, research analysts plainly believe Eledon Pharmaceuticals is more favorable than Phibro Animal Health.
Phibro Animal Health has a net margin of 1.75% compared to Eledon Pharmaceuticals' net margin of 0.00%. Phibro Animal Health's return on equity of 25.35% beat Eledon Pharmaceuticals' return on equity.
56.8% of Eledon Pharmaceuticals shares are held by institutional investors. Comparatively, 99.3% of Phibro Animal Health shares are held by institutional investors. 11.7% of Eledon Pharmaceuticals shares are held by insiders. Comparatively, 50.1% of Phibro Animal Health shares are held by insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a stock will outperform the market over the long term.
In the previous week, Phibro Animal Health had 10 more articles in the media than Eledon Pharmaceuticals. MarketBeat recorded 10 mentions for Phibro Animal Health and 0 mentions for Eledon Pharmaceuticals. Phibro Animal Health's average media sentiment score of 0.88 beat Eledon Pharmaceuticals' score of -0.05 indicating that Phibro Animal Health is being referred to more favorably in the news media.
Phibro Animal Health has higher revenue and earnings than Eledon Pharmaceuticals. Eledon Pharmaceuticals is trading at a lower price-to-earnings ratio than Phibro Animal Health, indicating that it is currently the more affordable of the two stocks.
Eledon Pharmaceuticals has a beta of 0.79, meaning that its share price is 21% less volatile than the S&P 500. Comparatively, Phibro Animal Health has a beta of 0.52, meaning that its share price is 48% less volatile than the S&P 500.
Summary
Phibro Animal Health beats Eledon Pharmaceuticals on 11 of the 16 factors compared between the two stocks.
Get Eledon Pharmaceuticals News Delivered to You Automatically
Sign up to receive the latest news and ratings for ELDN and its competitors with MarketBeat's FREE daily newsletter.
New MarketBeat Followers Over Time
This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Media Sentiment Over Time
This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Eledon Pharmaceuticals Competitors List
Related Companies and Tools
This page (NASDAQ:ELDN) was last updated on 2/22/2025 by MarketBeat.com Staff
Free ELDN Stock Alerts